OTCMKTS:PCHM PharmChem (PCHM) Stock Price, News & Analysis $3.70 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsHeadlinesShort InterestBuy This Stock About PharmChem Stock (OTCMKTS:PCHM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PharmChem alerts:Sign Up Key Stats Today's Range$3.70▼$3.7050-Day Range$3.68▼$3.9552-Week Range$2.95▼$3.98VolumeN/AAverage Volume5,002 shsMarket Capitalization$17.21 millionP/E Ratio15.42Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas. Read More Receive PCHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter. Email Address PCHM Stock News HeadlinesShareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public ShareholdersJuly 21, 2025 | prnewswire.comPharmChem, Inc. Announces Acquisition by Alcohol Monitoring Systems, Inc.July 21, 2025 | prnewswire.comGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. | Stansberry Research (Ad)PharmChem, Inc. (PCHM) - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comPharmChem, Inc. (PCHM) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comPharmChem, Inc. (PCHM) Latest Press Releases & Corporate News - Yahoo FinanceApril 29, 2025 | finance.yahoo.comPharmChem (OTC:PCHM) Stock Quotes, Forecast and News SummaryFebruary 9, 2025 | benzinga.comPharmChem considers strategic alternativesFebruary 3, 2025 | msn.comSee More Headlines PCHM Stock Analysis - Frequently Asked Questions How have PCHM shares performed this year? PharmChem's stock was trading at $3.06 at the beginning of 2025. Since then, PCHM stock has increased by 20.9% and is now trading at $3.70. How were PharmChem's earnings last quarter? PharmChem Inc. (OTCMKTS:PCHM) issued its quarterly earnings data on Thursday, August, 7th. The company reported $0.04 earnings per share for the quarter. The company had revenue of $1.56 million for the quarter. How do I buy shares of PharmChem? Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/07/2025Today8/24/2025Next Earnings (Estimated)11/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolOTCMKTS:PCHM CIKN/A Webwww.pharmchek.com Phone(855) 458-4100Fax817-605-6400Employees170Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.24 Trailing P/E Ratio15.42 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.38 million Net Margins17.92% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.09 million Price / Sales2.83 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,650,000Free Float3,839,000Market Cap$17.21 million OptionableNot Optionable Beta0.61 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:PCHM) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmChem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmChem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access